Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.1 USD | -1.37% | -9.25% | -3.83% |
May. 16 | Morgan Stanley Adjusts Ascendis Pharma Price Target to $140 From $116, Maintains Equal Weight Rating | MT |
May. 14 | US Equity Markets Close Higher Tuesday as Producer Prices Rise | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.83% | 7.04B | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Transcript : Ascendis Pharma A/S, Q1 2024 Earnings Call, May 02, 2024